Research by Chad Leaver

(Displaying 1 to 13 of 13)
Value-based procurement (VBP) is an advanced approach to purchasing that addresses the challenging problem of how to improve patient care and outcomes while containing healthcare...
The Conference Board of Canada | 27 pages | October 2022 | by Isabelle Gagnon-Arpin, Chad Leaver, Isabella Moroz, Nicholas Moroz
Cette mise à jour du rapport de 2017 du Conference Board du Canada intitulé Understanding the Gap, analyse la disponibilité des couvertures pour les médicaments sur ordonnance...
Le Conference Board du Canada | 23 pages | August 2022 | by Isabelle Gagnon-Arpin, Wanlin Chen, Chad Leaver
L’approvisionnement fondé sur la valeur (AFV) est une approche avancée en matière d’achat qui répond au défi épineux d'améliorer les soins et les résultats pour les...
Le Conference Board du Canada | 15 pages | August 2022 | by Isabelle Gagnon-Arpin, Chad Leaver, Isabella Moroz, Nicholas Moroz
Value-based procurement (VBP) is an advanced approach to purchasing that addresses the challenging problem of how to improve patient care and outcomes while containing healthcare...
The Conference Board of Canada | 14 pages | August 2022 | by Isabelle Gagnon-Arpin, Isabella Moroz, Nicholas Moroz, Chad Leaver
This data briefing, an update to The Conference Board of Canada’s 2017 Understanding the Gap, analyzes the availability of prescription drug coverage across the country and the...
The Conference Board of Canada | 22 pages | July 2022 | by Isabelle Gagnon-Arpin, Wanlin Chen, Chad Leaver
Interprovincial disparities in cancer outcomes persist. This primer explores the potential drivers of these disparities and how we can ensure every Canadian has a chance for the...
The Conference Board of Canada | 32 pages | July 2022 | by Sarah Lussier Hoskyn, Chad Leaver, Isabella Moroz
Les disparités interprovinciales en matière de cancer persistent. Ce condensé explore les facteurs à l’origine de ces disparités et les façons de nous assurer que chaque Canadien...
Le Conference Board du Canada | 36 pages | July 2022 | by Sarah Lussier Hoskyn, Chad Leaver, Isabella Moroz
This briefing looks at potential life years and economic value gained from breakthrough cancer therapies. Gaps in patients’ access to these treatments means lost economic value...
The Conference Board of Canada | 16 pages | February 2022 | by Kiefer Van Mulligen, Isabella Moroz, Chad Leaver
Ce rapport examine les années potentielles de vie et la valeur économique gagnées grâce aux traitements de pointe contre le cancer. Le fossé en matière d’accès des patients à ces...
Le Conference Board du Canada | 17 pages | February 2022 | by Kiefer Van Mulligen, Isabella Moroz, Chad Leaver
La maladie d’Alzheimer est un sujet de préoccupation grandissante au Canada. Les progrès scientifiques permettent de mieux comprendre sa pathologie et ouvrent la voie à de nouveaux...
Le Conference Board du Canada | 45 pages | January 2022 | by Isabella Moroz, Chad Leaver
Alzheimer’s disease is a growing concern in Canada. Scientific progress is shedding more light on its pathology and opening doors to new treatments. Are Canada’s healthcare systems...
The Conference Board of Canada | 39 pages | January 2022 | by Isabella Moroz, Chad Leaver
COVID-19 has had a huge impact on those at the front lines of healthcare. Here’s what Canadian clinicians want you to know about how it’s affected their work and well-being.
The Conference Board of Canada | 2 pages | December 2021 | by Nicola Waters, Chad Leaver
La COVID-19 a eu d’importantes répercussions pour les professionnels de la santé de première ligne. Voici ce dont les professionnels de la santé souhaitent faire part au sujet...
Le Conference Board du Canada | 2 pages | December 2021 | by Chad Leaver, Nicola Waters
(Displaying 1 to 13 of 13)